Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve high-cost, low-yield issues in Carlong anhydride production. New green route achieves 83.5% yield, 99.8% purity, and 90% less wastewater. Scale to 100MT/yr.
Solve high-cost palladium catalyst issues in tetrahydro-β-carbolinone production. Our CDMO expertise enables scalable, high-yield synthesis with cheap cobalt catalysts and simplified post-treatment.
Discover cost-effective cobalt-catalyzed synthesis of tetrahydro-β-carbolinone for anti-anxiety drugs. High yield, broad functional group tolerance, and scalable to 100 MT/yr. Reduce supply chain risks.
Solve lenvatinib impurity challenges with 98% purity, 80% yield. Our CDMO expertise ensures stable supply for pharma quality control.
Discover how copper-catalyzed oxidative coupling eliminates costly raw material steps and complex equipment for alpha-carbonyl amide production. Scale with 75-90% yields.
Discover a breakthrough synthesis method for chiral fluorine-containing quaternary carbon compounds with >90% enantioselectivity and mild conditions. Reduce supply chain risks for your API development.
Solve multi-step synthesis challenges with rhodium-catalyzed asymmetric [4+1] cyclization. 91% yield, 95% ee, and mild conditions for stable API intermediates. Contact for CDMO solutions.
Discover a scalable cobalt-catalyzed route for tetrahydro-β-carbolinone compounds. Eliminate palladium costs, improve substrate tolerance, and ensure 99%+ purity for your API production. Contact us for custom synthesis.
Eliminate CO handling risks and reduce costs with this novel Pd-catalyzed multi-component synthesis for high-purity carbonyl-bridged biheterocyclic compounds in pharmaceutical manufacturing.
Solve supply chain risks with one-step indole-3-carboxamide synthesis. High-yield, cost-effective route for API manufacturing. Contact for CDMO solutions.
Overcome low yield and complex purification in Favipiravir manufacturing. New one-pot method with 65% yield reduces costs and eliminates chromatography. Contact us for scalable production.
Eliminate CO gas handling risks and high costs in biheterocyclic synthesis. Discover scalable, high-yield routes for pharmaceutical intermediates with 99%+ purity.
Discover how nickel/photo-redox catalysis enables 78-83% yield in C-H cross-coupling for pharmaceutical intermediates with 99:1 regioselectivity. Reduce production costs and supply chain risks.
Solve complex synthesis challenges with this one-step palladium-catalyzed method. High-yield, cost-effective production of benzofuran-3-carboxamide for drug development. Reduce supply chain risks and scale efficiently.
Solve impurity challenges in flunaprazan intermediate production. 99.82% HPLC purity, 0.07% max impurity, 30% cost reduction. Scale to 100 MT/yr.
Reduce synthesis steps and costs with this one-pot method for high-purity pharmaceutical intermediates. Discover how this scalable process addresses supply chain risks and improves yield efficiency.
Discover a scalable, high-yield method for 2-pyrrolidone derivatives using nickel catalysis. Reduce production costs and improve functional group tolerance for pharmaceutical applications.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.
Solve CO handling risks & low yields in quinazolinone synthesis. Discover how solid CO substitute enables safe, scalable production for drug development. Contact for custom synthesis.
Discover how metal-free hydrodefluorination of trifluoromethyl olefins with 87% yield solves GMP compliance and supply chain risks for pharmaceutical intermediates.